Mission
OpenBiome is a nonprofit organization dedicated to advancing microbiome science and increasing access to fecal microbiota transplantation (FMT) for patients suffering from conditions such as recurrent Clostridium difficile infections. By partnering with researchers and healthcare providers, OpenBiome aims to leverage the potential of microbiome-based therapies to improve health outcomes globally.
Basic Information
Tax-Exempt
Founded in
2013
EIN
46-1681862
Total Assets
$9.439 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 3 of 3 goals
At a Glance
Investigational FMT Access Program
Access to investigational fecal microbiota transplantation for severe and fulminant infections like C. difficile.
Microbiome Conservation Initiatives
Efforts to conserve global microbiome diversity and support access to microbiome resources.
Global Health Programs
Developing therapies to address global health challenges such as malnutrition and mental health.
Impact Stats
70000
Total FMT Preparations
Over 70,000 FMT Preparations Distributed
OpenBiome has provided over 70,000 investigational fecal microbiota transplantation (FMT) preparations to patients.
1
Clinical Trial Milestones
First FMT-focused Clinical Trial in Africa
Supported the THRIVE trial, evaluating FMT for treating pediatric malnutrition in South Africa.
1
Collaborative Partnerships
Collaboration with the University of Minnesota
Partnered with UMN for distribution and research on FMT for recurrent C. difficile infections.
Our Programs
Investigational FMT Access Program
Access to investigational FMT treatments for patients with severe infections.
Learn MoreImpact Reports
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
58
42
/100
Program Expense Ratio
73.17%
8
/20
Program Revenue Growth
-89.03%
2
/20
Leverage Ratio
0.1693
16
/20
Working Capital Ratio
2.26
14
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 926.1K | 43.79% |
| Program Services | 112.6K | 5.32% |
| Investment Income | 161.8K | 7.65% |
| Sales of Non-Inventory Assets | 840 | 0.04% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 2.115M | 100.00% |
Related Nonprofits
International Centre for Diarrhoeal Disease Research Bangladesh
Med Research
Gastroenterology ResearchRome Foundation
Med Research
Gastroenterology ResearchGi Health Foundation Inc.
Med Research
Gastroenterology ResearchBrain Tumor Research Charity
Med Research
Gastroenterology ResearchAthletes Vs Crohns Inc.
Med Research
Gastroenterology Research